Profile data is unavailable for this security.
About the company
Youcare Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development of nucleic acid drugs. The products mainly include anti-infective drugs, cardiovascular drugs, digestive system drugs, hypoglycemic drugs, and active pharmaceutical ingredients (APIs). Product dosage forms cover various formats such as injections, lyophilized powder injections, tablets, and capsules. These products are applied in multiple therapeutic areas, including cardiovascular, diabetes, digestive system, anti-tumor, antiviral, and reproductive health. The Company primarily conducts its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)2.55bn
- Net income in CNY-233.99m
- Incorporated2001
- Employees3.28k
- LocationYoucare Pharmaceutical Group Co Ltd6 Hongda Middle RdBeijing Econ&Tech Dlvp AreaBEIJING 100176ChinaCHN
- Phone+86 1 087925985
- Fax+86 1 087925985
- Websitehttps://www.youcareyk.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KPC Pharmaceuticals Inc | 7.70bn | 530.05m | 9.41bn | 5.28k | 17.59 | 1.77 | -- | 1.22 | 0.7067 | 0.7067 | 10.21 | 7.01 | 0.6987 | 2.98 | 2.48 | 1,458,805.00 | 6.21 | 5.65 | 11.19 | 9.98 | 41.77 | 43.07 | 8.89 | 6.71 | 1.58 | -- | 0.1981 | 34.63 | -0.3408 | 0.6839 | 19.86 | 7.36 | -25.55 | 8.45 |
| North China Pharmaceutical Co Ltd | 9.79bn | 183.03m | 9.57bn | 10.09k | 52.40 | 1.74 | -- | 0.9775 | 0.1065 | 0.1065 | 5.69 | 3.21 | 0.453 | 2.91 | 4.26 | 970,873.20 | 1.30 | -0.2469 | 3.23 | -0.578 | 30.05 | 33.78 | 2.86 | -0.5243 | 0.4902 | 2.22 | 0.6254 | -- | -2.48 | -2.94 | 2,496.80 | -5.90 | 3.21 | 0.00 |
| Shandong Lukang Pharmaceutical Co Ltd | 6.19bn | 188.75m | 9.65bn | 6.39k | 44.18 | 2.10 | -- | 1.56 | 0.2089 | 0.2089 | 6.85 | 4.40 | 0.6891 | 3.69 | 6.77 | 969,079.80 | 2.20 | 2.78 | 3.60 | 5.00 | 22.98 | 22.76 | 3.20 | 4.17 | 0.7984 | 6.01 | 0.4324 | 31.07 | 1.41 | 10.80 | 60.30 | 26.62 | -19.55 | 24.01 |
| Chengdu Olymvax Biopharmaceuticals Inc | 709.13m | 64.21m | 9.74bn | 470.00 | 151.22 | 10.15 | -- | 13.73 | 0.1587 | 0.1587 | 1.75 | 2.36 | 0.3883 | 0.654 | 1.19 | 1,508,792.00 | 3.45 | 3.25 | 5.00 | 4.81 | 92.66 | 93.62 | 8.88 | 8.11 | 1.42 | 8.30 | 0.2906 | 7.39 | 18.69 | 26.88 | 18.24 | -- | 48.00 | -- |
| Youcare Pharmaceutical Group Co Ltd | 2.55bn | -233.99m | 9.92bn | 3.28k | -- | 2.89 | -- | 3.89 | -0.5306 | -0.5306 | 5.75 | 7.62 | 0.4537 | 2.18 | 4.03 | 777,123.10 | -4.30 | 5.90 | -5.97 | 8.92 | 47.55 | 63.64 | -9.48 | 7.49 | 1.49 | -41.24 | 0.1633 | 66.99 | -9.90 | -2.48 | -33.05 | -15.40 | 19.36 | -- |
| Chongqing Taiji Industry Group Co Ltd | 10.04bn | -352.52m | 10.02bn | 11.97k | -- | 2.83 | -- | 0.9979 | -0.8238 | -0.8238 | 18.98 | 6.42 | 0.7032 | 2.85 | 3.55 | 838,688.20 | -2.36 | 0.9924 | -6.94 | 3.04 | 26.30 | 43.37 | -3.35 | 1.08 | 0.4906 | 0.5756 | 0.5914 | 22.39 | -20.72 | 1.24 | -96.76 | -- | -3.36 | -- |
| Chongqing Genrix Biophrmctcl Co Ltd | 225.16m | -583.52m | 10.24bn | 743.00 | -- | 5.73 | -- | 45.47 | -1.59 | -1.59 | 0.6141 | 4.88 | 0.0712 | 0.3088 | 10.33 | 303,044.90 | -18.45 | -- | -19.95 | -- | 90.99 | -- | -259.16 | -- | 7.37 | -- | 0.3694 | -- | 2,384.11 | -- | 0.5049 | -- | -- | -- |
| Shanghai Yizhong Pharmaceutical Co Ltd | 247.05m | 22.96m | 10.31bn | 65.00 | 440.89 | 7.06 | -- | 41.75 | 0.1132 | 0.1132 | 1.22 | 7.07 | 0.163 | 0.9556 | 2.26 | 3,800,801.00 | 1.51 | 5.44 | 1.58 | 5.64 | 81.39 | 92.99 | 9.30 | 36.90 | 7.84 | -- | 0.00 | 32.30 | -51.83 | -- | -95.68 | -- | 10.96 | -- |
| Liaoning Chengda Biotechnology Co Ltd | 1.47bn | 177.94m | 10.78bn | 1.81k | 59.79 | 1.15 | -- | 7.34 | 0.433 | 0.433 | 3.56 | 22.54 | 0.1482 | 0.6786 | 1.24 | 813,192.10 | 1.79 | 8.07 | 1.86 | 8.36 | 79.03 | 84.98 | 12.11 | 35.75 | 19.28 | -- | 0.0013 | 44.77 | -4.22 | -0.0082 | -26.42 | -13.26 | -4.72 | -- |
Data as of Feb 06 2026. Currency figures normalised to Youcare Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.97%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 14.89m | 3.31% |
| E Fund Management Co., Ltd.as of 30 Sep 2025 | 9.77m | 2.17% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 9.41m | 2.09% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 8.89m | 1.98% |
| Fullgoal Fund Management Co., Ltd.as of 30 Sep 2025 | 8.50m | 1.89% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 4.35m | 0.97% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 4.29m | 0.95% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 3.15m | 0.70% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2025 | 2.14m | 0.48% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 1.97m | 0.44% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
